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Abstract
Background: The Warburg phenotype in cancer cells has been long recognized, but there is still
limited insight in the consecutive metabolic alterations that characterize its establishment. We
obtained better understanding of the coupling between metabolism and malignant transformation
by studying mouse embryonic fibroblast-derived cells with loss-of-senescence or H-RasV12/E1A-
transformed phenotypes at different stages of oncogenic progression.
Results: Spontaneous immortalization or induction of senescence-bypass had only marginal effects
on metabolic profiles and viability. In contrast, H-RasV12/E1A transformation initially caused a
steep increase in oxygen consumption and superoxide production, accompanied by massive cell
death. During prolonged culture in vitro, cell growth rate increased gradually, along with tumor
forming potential in in vitro anchorage-independent growth assays and in vivo tumor formation
assays in immuno-deficient mice. Notably, glucose-to-lactic acid flux increased with passage
number, while cellular oxygen consumption decreased. This conversion in metabolic properties
was associated with a change in mitochondrial NAD+/NADH redox, indicative of decreased
mitochondrial tricarboxic acid cycle and OXPHOS activity.
Conclusion: The high rate of oxidative metabolism in newly transformed cells is in marked
contrast with the high glycolytic rate in cells in the later tumor stage. In our experimental system,
with cells growing under ambient oxygen conditions in nutrient-rich media, the shift towards this
Warburg phenotype occurred as a step-wise adaptation process associated with augmented
tumorigenic capacity and improved survival characteristics of the transformed cells. We
hypothesize that early-transformed cells, which potentially serve as founders for new tumor masses
may escape therapies aimed at metabolic inhibition of tumors with a fully developed Warburg
phenotype.
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Background
Carcinogenesis is a multi-step process that not only
involves activation of oncogenes and/or inactivation of
tumor suppressor genes [1], but also alterations in energy
metabolism. Growth and viability of malignant cells is
strongly dependent on their ability to adopt an altered
metabolic profile that fulfills the synthetic and bioener-
getic requirements for fast and uncontrolled growth. This
metabolic phenotype is characterized by a shift from oxi-
dative phosphorylation (OXPHOS) towards aerobic glyc-
olysis as the main source of ATP production, a
phenomenon first described by Otto Warburg [2].
The increased dependency of cancer cells on aerobic glyc-
olysis is a well-recognized hallmark [3], but still relatively
little is known about the factors that are in control during
the early phases of the transformation process. Also, the
issue whether or not this metabolic phenotype is an abso-
lute prerequisite for advanced cancer progression is sub-
ject for debate [4]. Carbohydrate metabolism must
warrant sufficient supply of ATP for cell growth, but also
maximize macromolecular biosynthesis [5]. Intriguingly,
cancer cells develop the ability to escape from senescence
and apoptosis, processes in which glycolysis and mito-
chondrial pathways are actively engaged [6]. Furthermore,
tumor cells maximize antioxidant capacity via the glutath-
ione system, which is coupled to increased flux through
the glycolysis-coupled pentose phosphate pathway (PPP)
[7]. The question why tumor cells have a relatively high
glycolytic rate compared to OXPHOS activity therefore
goes well beyond the basics of which of the two processes
is more efficient in terms of ATP production.
Carbohydrate metabolism has been studied extensively in
the context of oncogene-induced cellular signaling, as
mutations in metabolic enzyme-encoding genes them-
selves are rarely the direct cause of cancer [8]. For example,
increased glycolysis is triggered by activation of the PI3K/
AKT signaling pathway [5,9] or the p53 pathway [10]. An
important aspect that has been less well studied is how
metabolism changes dynamically in a transforming cell
population. The Warburg phenotype in solid tumors in
vivo is thought to be the result of multiple adaptive
changes in metabolism in response to both cell-internal
and -external cues. Hence the conversion from a dysplasic
cell towards a full-blown cancerous state [11] is not just
caused by genetic changes alone.
The step-wise development and associated metabolic
adjustments of patient tumor cells is difficult to monitor,
as it is virtually impossible to obtain a population of
founder cells from which the tumor originally evolved.
We therefore developed populations of mouse embryonic
fibroblasts (MEFs) to investigate how adaptations in glyc-
olytic-mitochondrial capacity are accomplished during
oncogenic transition. Specifically, we studied cells in an
immortalized state or directly after oncogenic transforma-
tion by mutant H-RasV12 and E1A. These latter cells were
followed during the step-wise conversion to a fully cancer-
ous state in vitro and passage through immune-deficient
mice in vivo, which gave us the opportunity to analyze
metabolism in a broad window of tumor stages. We
focused on the sequential order in which adaptations in
glycolytic-mitochondrial capacity were accomplished
under constant extrinsic conditions of culture medium
and oxygenation.
Our data show a sharp increase in oxygen consumption
and a high rate of formation of reactive oxygen species
(ROS) directly after H-RasV12/E1A transformation, with a
smooth transition towards higher glycolytic rates later
during tumorigenic development. We hypothesize that
the immediate increase in oxygen consumption and
OXPHOS activity sets a new and delicate balance in cell
fate specification, driving cells in an "adapt-or-perish"
regime. Subsequent escape from this situation is associ-
ated with gain in survival characterized by a glycolytic
switch even under ambient oxygen levels, an adaptation
typical for the Warburg phenotype.
Results
Generation of cell populations
We set up a new cell model system for the study of meta-
bolic characteristics of immortalized and tumorigenic
cells, all derived from one defined and genetically stable
founder cell population, mouse embryonic fibroblasts
(Prim-MEF; Table 1). Immortalized cells fulfill one early
hallmark of cancer, namely limitless replicative life span
[1]. The spontaneously immortalized population (Imm-
MEF) was established by passaging the pool of Prim-MEFs
through the replication bottleneck [12]. This transition is
likely associated with the random acquisition of one or
more genetic alterations such as mutation of p53 or loss
of p19ARF [13]. A second pool of cells with a senescence-
bypass phenotype (TBX2-MEF), thus genetically distinct
from the spontaneously immortalized pool, was gener-
ated by overexpression of TBX2 in Prim-MEF at passage 2.
Co-expression of mutant RasV12 and adenovirus E1A in
primary mouse cells constitutes a model of multistep
tumorigenesis for establishment of oncogenic cell popula-
tions [14]. We used this principle to establish MEF popu-
lations at different phases of oncogenic transition towards
a malignant phenotype via retroviral transduction of
pLPC-E1A-ires-H-RasV12 in Prim-MEF cells at passage 2.
The resulting cell pool was studied (i) directly after selec-
tion as in vitro cultivated cells (Ras-Low Passage: 5–10),
(ii) after prolonged passage in vitro (Ras-High Passage: >
25) or (iii) after injection of Ras-HP (p25) cells subcuta-
neously in the flank of immune-deficient mice and re-
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establishment as tumor cell populations in in vitro culture
(Ras-TUM; between +3 and +10 passages after re-cultur-
ing). Each population was propagated as a mixed pool of
cells with distinct viral DNA integration sites in the
genome, and possibly differences in expression levels of
the transforming transgenes. Thus, we avoided clonal
analyses and excluded the possibility that one or few
selective integrations of the transgene would dominate
the phenotypic outcome.
Changes in cell morphology
Cell morphology in Prim-MEF, Imm-MEF and TBX2-MEF
populations was largely similar, but introduction of H-
RasV12/E1A induced prominent morphology changes
and resulted in a marked reduction in cell diameter (Table
1; Additional file 1: Fig. S1; Fig. S2A). Notably, the cellular
protein concentration (Additional file 1: Fig. S2B-C) was
decreased in immortalized cells, while it tended to
increase in H-RasV12/E1A transformed cells.
Growth characteristics of transformed cells
The effects of immortalization and H-RasV12/E1A expres-
sion on growth rate were studied. Cell doubling rates of
Prim-MEF (between passage 3–8) and TBX2-MEF
(between passage 15–25) did not differ (20 hrs; Table 1),
but Imm-MEF (between passage 20–30) grew slower (+4
hrs). Doubling rate was reduced by three hours in Ras-LP
cells, by eight hours in Ras-HP and by five hours in Ras-
TUM cells. Our analyses revealed that cultures of Ras-LP
cells contained a high percentage of detached, mostly
dead, cells in the culture medium as assayed by tryphan
blue staining (Fig. 1). This indicates that we underesti-
mated the cell division time in these cells because of the
reduced viability in the population. The transition from
Ras-LP to Ras-HP was associated with a greatly improved
survival chance and a drastic reduction in the amount of
non-adherent cells in culture. We subsequently deter-
mined anchorage-independent growth characteristics of
our cell populations in soft agar colony formation assays,
and evaluated tumor forming potential in immune-defi-
cient mice. After nine days, 5 to 7-fold more colonies had
formed in Ras-HP and Ras-TUM soft agar assays compared
to Ras-LP, whereas Imm-MEF, Prim-MEF and TBX2-MEF
cultures gave no colonies at all (Table 1). Subcutaneous
injection of cells in immune-deficient mice revealed that
Ras-HP-derived tumors were four times larger than Ras-LP
Table 1: Characteristics of primary, immortalized and tumorigenic cells in the panel
cell 
population
abbreviation description cell diameter 
(μm)
cell volume 
(pL)
number of 
colonies in 
soft agar
tumor size 
(mm2) in 
BALB/c nu/nu
cell doubling 
time (h)
Primary MEF Prim-MEF Isolated from 
12–14.5 day-old 
embyos
16.3 ± 1.0 (3) 2.6 ± 0.5 (3) none n.a. 20.5 ± 0.7 (6)
Immortalized 
MEF 
(spontaneous)
Imm-MEF Senescence 
bypass 
(3T3 passaging)
16.5 ± 0.7 (3) 2.7 ± 0.3 (3) none n.a. 24.1 ± 1.1 (6)
Immortalized 
MEF (TBX2)
TBX2-MEF Retroviral 
transducton 
TBX2 gene
15.5 ± 0.3 (4) 2.1 ± 0.1 (4) none n.a. 19.9 ± 0.9 (6)
RasV12/E1A
MEF 
(low passage)
RAS-LP Retroviral 
transducton 
E1A/RasV12
11.0 ± 1.0 ** 
(4)
0.82 ± 0.2 ** 
(4)
131 ± 68 (5) 131 ± 62 (9) 16.8 ± 1.6 # (6)
RasV12/E1A 
MEF 
(high passage)
RAS-HP Retroviral 
transducton 
E1A/RasV12
10.1 ± 0.4 *** 
(4)
0.58 ± 0.1 *** 
(4)
880 ± 164 †† (5) 497 ± 182 † (9) 12.2 ± 0.7*** ‡ 
(8)
RasV12/E1A 
MEF (tumor)
Ras-TUM RAS-HP passage 
in BALB/c nu/nu 
mice
10.5 ± 0.3 *** 
(3)
0.65 ± 0.1 *** 
(3)
705 ± 146 †† (7) n.a. 15.0 ± 1.0 ** (7)
Cell diameter, doubling time, and in vitro and in vivo tumorigenic characteristics were analyzed. Values represent average ± SEM (n). Cell diameter 
and cell doubling time decrease significantly in H-RasV12/E1A-transformed cells. Primary and immortalized cells do not form tumors in vitro or in 
vivo, whereas tumorigenic capacity of H-RasV12/E1A-transformed cells increases with passage number.
1For cell diameter analysis, approximately 120 cells per population were analyzed in each of the independent experiments.
2Soft agar assays were carried out in duplicate in each of the independent experiments.
3In vivo tumor assays were conducted on a total of nine animals as described in Material and Methods.
4For cell growth analysis and cell doubling time calculation, at least six independent experiments, each in duplicate, were conducted. Cells were 
seeded at 128,000 (Prim-MEF, Imm-MEF, TBX2-MEF) or 200,000 (Ras-LP, -HP, -TUM) cells per well of a 6-well plate.
Statistics:
**: p < 0.01; ***: p < 0.001 compared to Prim-MEF (one-way ANOVA/Bonferroni)
‡: p < 0.05 compared to Ras-LP (one-way ANOVA/Bonferroni)
†: p < 0.05; ††: p < 0.01 compared to Ras-LP (Student's t-test)
#: p < 0.10 for comparison Prim-MEF – Ras-LP (Student's t-test)
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tumors after four weeks (Table 1). We conclude that the
capacity of H-RasV12/E1A-transformed cells to form
tumors increases with cell culture passage number.
Because all analyses were performed on cells growing at
ambient oxygen condition in nutrient-rich culture media,
we also analyzed the impact of low (2%) oxygen levels on
cell growth and survival in soft agar, under conditions
where diffusion limitation restricts nutrient supply. Under
both high and low oxygen tension, the colony forming
capacity of Ras-HP cells in soft agar was higher than that
of Ras-LP cells. However, Ras-LP cells cultured at 2% oxy-
gen formed 3-fold more colonies than at 21% oxygen,
whereas Ras-HP formed only 1.3-fold more colonies at
2% oxygen (Fig. 2A–B). Ambient environmental oxygen
supply as an extrinsic parameter thus plays an important
negative role in fate specification of cells immediately
after H-RasV12/E1A transformation.
Lactic acid production in transformed cells
We further concentrated on the question which cell-
intrinsic metabolic parameters play a role in H-RasV12/
E1A-initiated tumor cell development. As increased lactic
acid production is a hallmark change in intermediary
metabolism of tumor cells [15], we determined lactic acid
levels in culture medium at 24, 48 and 72 hours after seed-
ing cells, alongside with cell counts (see above). This ena-
bled calculation of lactic acid production per average cell
in the time interval analyzed (Additional file 1: Fig. S3A).
Because protein content per cell was not stable in cells of
different size and volume (Additional file 1: Fig. S2B-C),
we corrected for protein content per cell to enable accurate
comparison between cells with different composition and
morphology. The results presented in Fig. 3A show that
lactic acid production in μ moles/mg protein were equal
in Prim-MEF, Imm-MEF and TBX2-MEF, but increased
1.5-fold in Ras-LP cells, 2.5-fold in Ras-HP and 3.5-fold in
Ras-TUM cells compared to Prim-MEF. Prolonged passag-
ing of H-RasV12/E1A transformed cell populations
induced a gradual shift towards a higher glycolytic rate.
Steep increase in oxygen consumption rate immediately 
after transformation
The oxygen consumption rate was determined in normal-
ized relative fluorescence units by analyzing trypsinized
cells in BD Oxygen Biosensor multi-well plates, and sub-
sequently corrected for protein content per cell (Fig. 3B;
see Additional file 1: Fig. S3B). This parameter was rela-
Viability of Ras-LP and Ras-HP cells in standard culture conditionsF gure 1
Viability of Ras-LP and Ras-HP cells in standard culture conditions. Adherent and non-adherent cells were harvested 
after 72 hours in culture, stained using tryphan-blue, and counted. A: Data presented as percentages of total amount of cells. 
***: p < 0.001 (n = 5). Ras-LP cultures contain relatively more detached cells in the medium, of which the majority is dead. B: 
Data presented in (A) in absolute counts (n = 5). ***: p < 0.001 (n = 5). Ras-HP cell cultures contain relatively and absolutely 
more viable cells.
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tively low in Prim-MEF and immortalized cell popula-
tions, but H-RasV12/E1A expression immediately
induced a 5.6-fold increase in basal oxygen consumption
rate per mg protein. Ras-HP cells showed 2.8-fold reduced
oxygen consumption compared to Ras-LP, while the oxy-
gen consumption of Ras-TUM cells was reverted to the
level found in Prim-MEF cells.
Measurement of maximum oxygen consumption after
uncoupling by FCCP revealed that mitochondria in Ras-
LP cells function at 66% of their maximum respiratory
capacity compared to only 25% in Prim-MEF and immor-
talized cells (Additional file 1: Fig. S4A-B). Oxygen con-
sumption in all cell types was almost completely blocked
by Complex V inhibitor oligomycin (Additional file 1: Fig.
S4C), indicating that it was fully coupled to ATP produc-
tion. Moreover, oxygen consumption was completely
blocked by Complex III inhibitor myxothiazol and only
marginally affected by extracellular supplementation of
NADH, indicating that the vast majority of oxygen con-
sumption occurred in mitochondria and was not due to
membrane oxidase activity (Additional file 1: Fig. S4D),
which significantly contributes to cellular oxygen con-
sumption in a variety of tumor cell lines [16].
To verify these findings in an independent setting and to
allow a direct calculation of fmoles oxygen consumed, we
determined proton extrusion rate (indicative of anaerobic
glycolytic rate) and oxygen consumption rate (indicative
of mitochondrial OXPHOS) cells in adherent culture con-
ditions using real time extracellular flux analysis [17]. In
accordance with lactic acid production, the normalized
proton production rate (PPR; Fig. 3C) per cell increased
step-wise in the transition Prim-MEF – Ras-LP – Ras-HP –
Ras-TUM. Analysis of oxygen consumption rate in adher-
ent cells (OCR; Fig. 3C) in real time showed drastically
increased oxygen consumption in Ras-LP cells compared
to Prim-MEF, which again appeared diminished in Ras-
HP and Ras-TUM. Thus, H-RasV12/E1A transformation
directly induced high OXPHOS activity, which gradually
diminished during prolonged culture in vitro and passage
through immune-deficient mice.
Anchorage-independent growth in soft agar at different oxygen conditionsFigure 2
Anchorage-independent growth in soft agar at different oxygen conditions. A: Growth of Ras-LP cells in soft agarat 
2% and 21% environmental oxygen. Lowering external oxygen levelsresults in a 3-fold increase in the number of colonies per 
cm2. *:p < 0.05 (Student's t-test). B: Growth of Ras-HP cells in soft agar at2% and 21% environmental oxygen. Lowering exter-
nal oxygen levels inRas-HP soft agar cultures results in only a marginal 1.3-fold andnon-significant increase in colony number, 
showing that a glycolyticshift in these relatively glycolytic cells does not result in a largeincrease in viability and colony forma-
tion of cells in the soft agar.
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Figure 3 (see legend on next page)
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Expression levels of glycolytic and mitochondrial proteins
The shift in the balance between aerobic and anaerobic
metabolism may be associated with abundance of several
key enzymes in glycolytic and mitochondrial pathways, or
by altered metabolite flux through these reactions [18].
Table 2 and Additional file 1 (Fig. S5A-B) show that levels
of glycolytic pathway enzymes and mitochondrial
enzymes were surprisingly constant (variations less than
50%) in all cell populations, suggesting that altered flux
rates are responsible for the increased glycolytic flux in
Ras-HP and Ras-TUM cells. We considered possible
altered glycolytic flux regulation at the level of the LDH
isoenzyme expression, but found only marginal changes
in the LDH isoenzyme profile (data not shown).
Expression levels of proteins involved in cellular pyridine 
nucleotide balance
The setting of the cytosolic NAD+/NADH ratio determines
the enzymatic rate of the GAPDH reaction, the LDH reac-
tion, and the shuttling of NADH towards mitochondria
via the malate-aspartate shuttle and is therewith an
important determinant of pyruvate flux. We investigated if
the alteration of flux through glycolytic and mitochon-
drial pathways was associated with changes in enzymes
that determine the NAD+/NADH redox couple. Cytosolic
malate dehydrogenase (MDH1) levels were two-fold
higher in H-RasV12/E1A transformed than in non-trans-
formed cells. In contrast, mitochondrial MDH (MDH2)
levels appeared similar in all cell populations (Table 2;
Additional file 1: Fig. S5C). Furthermore, the expression
level of NAMPT, a key enzyme in the NAD+ salvage path-
Lactic acid production, oxygen consumption and proton production rateFigure 3 (see previous page)
Lactic acid production, oxygen consumption and proton production rate. A: Lactic acid production in μ moles/mg 
protein (mean ± SEM). Lactic acid production was measured in media samples taken from the cell cultures used to obtain the 
cell doubling time data in Table 1. Six independent experiments, each in duplicate, were conducted for all cell populations, 
except Ras-HP (n = 8) and Ras-TUM (n = 7). Lactic acid production increases with passage number in H-RasV12/E1A-trans-
formed cells. ***:p < 0.001 compared to Prim-MEF. #:p < 0.05; ##:p < 0.01; ###:p < 0.001 for Ras-LP – Ras-HP – Ras-TUM 
intercomparisons (one-way ANOVA/Bonferroni). B: Oxygen consumption in NRFU/min/mg protein measured in BD oxygen 
biosensor plates (mean ± SEM). Each experimental value represents n = 3 (Prim-MEF, Imm-MEF, TBX2-MEF) or n = 6 (other 
cell populations) independent assays, each carried out in triplicate. Cells were seeded at 200,000 cells per well of a 384-well 
plate. Oxygen consumption peaks immediately after H-RasV12/E1A transformation, and then decreases with passage number. 
***:p < 0.001 compared to Prim-MEF. ###:p < 0.001 for Ras-LP – Ras-HP – Ras-TUM intercomparisons (one-way ANOVA/
Bonferroni). C: Proton production rate (PPR) and oxygen consumption rate (OCR) per cell measured in Seahorse XF24 anal-
ysis 48 hours post seeding (mean ± SEM; n = 6, except Ras-HP, n = 4). Prim-MEF, Imm-MEF and TBX2-MEF cells were seeded 
at 25,000/well. Ras-LP, Ras-HP, Ras-TUM cells were seeded at 30,000/well. PPR: **:p < 0.01 compared to Prim-MEF. OCR: 
##:p < 0.01 compared to Prim-MEF (one-way ANOVA/Bonferroni). These data confirm the gradual increase in cellular acidifi-
cation and decrease in oxygen consumption described in (A) and (B) in real time analysis.
Table 2: Protein expression levels in primary, immortalized and tumorigenic cell populations
Prim-MEF Imm-MEF TBX2-MEF RAS-LP RAS-HP RAS-TUM
Glycolysis
Aldolase 1.0 1.1 1.1 1.0 1.0 1.1
GAPDH 1.0 0.9 1.0 1.4 1.4 1.5
Pyruvate kinase 1.0 0.8 0.8 1.0 1.1 1.0
LDH-A 1.0 0.8 0.8 1.0 1.1 1.2
OXPHOS
Porin 1.0 1.3 1.3 1.4 0.9 1.0
B39 1.0 0.7 0.7 1.3 1.5 1.5
PDH-E2 1.0 1.0 1.2 1.2 1.0 1.2
PDH-E1a 1.0 1.0 1.1 1.3 1.4 1.2
NAD metabolism
cMDH 1.0 0.6 1.2 2.4 3.3 2.9
mMDH 1.0 0.9 0.9 1.3 1.1 1.1
NAMPT* nd nd nd 1.0 1.9 2.6
Semi-quantitative Western blot was performed as described in Material and Methods. Protein expression levels of Prim-MEF were arbitrarily set to 
1.0. Glycolytic and mitochondrial enzymes do not show upregulation at the protein level in immortalized or transformed cell populations. Two 
enzymes involved in cellular NADH metabolism, MDH1 and NAMPT showed increased protein levels.
*Indexed on Ras-LP (1.0): protein levels in Prim-MEF were extremely low and could not be reliably quantified (nd: not detectable).
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way and one of the main regulators of total cellular NAD
level, increased immediately after H-RasV12/E1A expres-
sion. The induction of MDH1 and NAMPT could have
important implications for the pyridine nucleotide bal-
ance.
Increased pyridine nucleotide levels in H-RasV12/E1A 
transformed cells
Steady state levels and redox state of pyridine nucleotides
are important indicators and regulators for cell state and
metabolic signaling activity [19]. We studied the pyridine
nucleotide levels by HPLC to reveal if adjustments in the
balance between glycolysis and OXPHOS were indeed
reflected in changes in steady-state levels of total cellular
ATP, NAD+, NADH, NADP, or NADPH (see Additional
file 2; Additional file 1: Fig. S6). This analysis showed a
30–40% increase in total cellular NAD(H) (NAD+ plus
NADH) levels, but not NADP(H) (NADP+ plus NADPH)
levels, in RasV12/E1A transformed populations relative to
unchanged total cellular ATP level. Unfortunately, neither
of the two HPLC analysis methods used allowed reliable
quantification of the NAD+/NADH or NADP+/NADPH
redox status due to methodological constrains.
Mitochondrial NAD+/NADH ratio is correlated with 
OXPHOS activity
More detailed information on levels and compartmental-
ization of non-protein bound NAD(P)H was obtained by
autofluorescence microscopy [20]. NAD(P)H signals, the
majority of which is NADH, were largely confined to
mitochondria and nucleus. Two to three-fold brighter
autofluorescence signals were recorded from mitochon-
dria and nuclei of cells in the Ras-HP and Ras-TUM pools
(Fig. 4A), suggesting increased NAD(P)H levels in these
populations. However, quantitative interpretation of this
finding may be complicated by deviant morphological
appearance of mitochondria in these two populations
compared to Prim-MEF cells. We therefore studied the
mitochondrial NAD+/NADH redox state specifically by
concentrating on the relationship between autofluores-
cence levels and complex I (CI) activity in the electron
transport chain (ETC) of the OXPHOS system, a parame-
ter that is independent of cell morphology. Treatment
with CI inhibitor rotenone blocks NADH consumption
and elicits a direct increase in mitochondrial NADH level.
Measurement of the difference in NADH fluorescence
before and after rotenone administration thus is indica-
tive for the fraction of cellular NADH that is actually used
for turnover in OXPHOS activity. Fig. 4B and 4C convinc-
ingly show that the NADH-signal set point is at 66% of the
maximum rotenone-value for Ras-LP, compared to 78–
84% for all other cell populations. These results strongly
suggest that Ras-LP cells have intrinsic properties that
force them to use a larger fraction of their NADH content
for flux through OXPHOS than Ras-HP or Ras-TUM cells,
explaining the relatively high oxygen consumption of our
Ras-LP cells. Ras-LP cells switched at passage six to galac-
tose containing medium, a condition used to further max-
imize flux through mitochondrial OXPHOS [21], initially
grew slower, and died around passage fourteen (data not
shown). To us, these observations suggest that it is impos-
sible to reach the high passage stage solely on aerobic
metabolism. Ras-HP cells did not survive the switch to
galactose containing medium and died within a few days,
indicating that their aerobic metabolic capacity is not suf-
ficient to meet cellular growth demands. As a final control
for our assays, we forced use of mitochondrial OXPHOS
in TBX2-MEF cells by subjecting them to growth on galac-
tose/pyruvate medium for 6 days. This regime resulted in
a 2.5-fold stimulation of the mitochondrial oxygen con-
sumption rate (Additional file 1: Fig. S7A) and induced a
decrease of the intramitochondrial NADH-signal set point
from 85% to 65% of the maximal rotenone value (Addi-
tional file 1: Fig. S7B).
Increased oxygen consumption is correlated to increased 
superoxide production
The increased oxygen consumption rate and the altered
mitochondrial NAD(H)-redox setpoint in mitochondria
prompted us to test if superoxide levels, as indicators of
mitochondrial respiratory activity, were higher in Ras-LP
cells. Superoxide levels per cell were monitored by HEt
conversion to ethidium. Subsequent FACS analysis
revealed two-fold higher levels in Ras-LP cells compared
to Ras-HP and Ras-TUM cells on a per cell basis (Fig. 4D).
Based on the absence of significant membrane oxidase
activity (Additional file 1: Fig. S4D), we concluded that
the majority of superoxide is generated in the mitochon-
dria. In a control experiment, we showed that the switch
to galactose in TBX2 cells has similar inducing effects on
HEt fluorescence (Additional file 1: Fig. S7C).
Discussion
We performed a comprehensive analysis of sequential
metabolic changes that occur in a panel of cell popula-
tions with loss of cell-cycle arrest or increased tumorigenic
potential. These analyses gave us new insight in the rela-
tion between oncogenic transformation and the develop-
ment of the typical Warburg phenotype. The direct
relatedness of the different cell pools – all pools were
derived from the same primary MEFs ground state cell
population – gave us a unique opportunity to do compar-
ative profiling and highlight the early-late order of adap-
tive metabolic changes in energy metabolism that occur
during solid tumor development.
Two genetically independent immortalization procedures
had only minor effects on cell size, morphology, and car-
bohydrate metabolism, and yielded metabolic pheno-
types with strong similarity to the original Prim-MEF cells.
Molecular Cancer 2009, 8:54 http://www.molecular-cancer.com/content/8/1/54
Page 9 of 14
(page number not for citation purposes)
Figure 4 (see legend on next page)
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In contrast, H-RasV12/E1A transformation caused a
prominent change from flattened to spherical appearance
and smaller volume (see also [22]). Similar changes have
been reported before for other transformed cell types
[23,24].
One of the most conspicuous observations in our study
was that the metabolic phenotype initially switched to
aerobic, OXPHOS-based, immediately after transforma-
tion. The augmented OXPHOS rate in Ras-LP cells was
associated with increased total cellular NAD(H) levels, an
altered mitochondrial NAD+/NADH setpoint, increased
oxygen consumption and increased superoxide produc-
tion. We think that OXPHOS induction in early trans-
formed cells may be a general concept that precedes the
well-documented Warburg effect or shift to aerobic glyco-
lysis. The initial switch to aerobic metabolism has also
been reported after oncogene-mediated transformation of
human mesenchymal stem cells [25], human epithelial
cells [26,27] and human breast cancer cells [28]. At this
stage it is, however difficult to draw direct comparison
between our findings in mouse cells and findings in the
different human systems, as panels with related human
cells lines comparable to our panel do not exist or were
generated via use of increasing numbers of oncogenes
[27]. Future work, involving analyses of metabolic fate
specification in panels with human cells from mesenchy-
mal, epithelial, or progenitor-stem cell origin, will there-
fore be needed to verify the prediction of high OXPHOS
activity in early transformed cells.
Importantly, our results indicate that environmental fac-
tors can exert strong influence on viability of tumor cells
during the early phase of the transformation process.
Anchorage-independent growth capacity of Ras-LP cells
increased under low oxygen conditions, presumably by a
direct suppressive effect on the high intrinsic and "unbal-
anced" mitochondrial activity or simply by better cou-
pling of glycolytic-mitochondrial pathways. For better
explanation and discrimination between these possibili-
ties a detailed comparison of relative mitochondrial and
glycolytic pathway activity in cells in colonies formed
under ambient oxygen or in hypoxia would be imperative.
Unfortunately, such pathway analysis on relatively small
numbers of cells in soft agar in situ is currently technically
not possible, so we have to leave this analysis for future
work. If we may extrapolate these findings to the in vivo
situation, we would predict that nutrient levels in the
environment, including oxygen levels, may determine the
fate of early dysplastic cells in tissues. In the light of our
results, we predict that low oxygen or hypoxia would
enhance their capacity to grow as tumors, as was already
proposed in the model of Gatenby and Gillies [29].
The later trajectory of oncogenic transformation displayed
by our cell panel involved a gradual shift towards higher
anaerobic glycolysis rates over 20 passages in vitro and
passage through immune-deficient mice, accompanied
with clear gain in survival ability. We demonstrate here
that the pools of cells that progress towards a tumorigenic
phenotype go through a distinct series of adaptational
changes. Although this metabolic rewiring may also be
controlled by specific mutations in regulatory genes that
become dominant in the entire pool, we consider it more
likely that cell-intrinsic metabolic signaling mechanisms,
acting within the windows set by the culture conditions
(i.e. nutrient and O2 supply) used in our experiments,
drive the gradual shift from OXPHOS to glycolysis. We
draw this conclusion because we observed a similar step-
wise drift in metabolic phenotype in a parallel series of
cell populations that were independently derived from
MEFs from mice with a combined defect in phosphotrans-
fer enzymes CK-B and AK1 [30]. At this point it is impor-
tant to note that this entire transition trajectory occurred
Analysis of NADH autofluorescenceFigure 4 (see previo s page)
Analysis of NADH autofluorescence. A: Mitochondrial and nuclear NADH autofluorescence levels (mean ± SEM of a min-
imum of 3 independent experiments) expressed in absolute grey levels. Note that the signals were obtained from cells with 
clearly distinct morphology, which makes intercomparison of Prim-MEF, Imm-MEF and TBX2-MEF on the one hand, and Ras-
transformed populations on the other, difficult. Absolute NADH autofluorescence increases gradually with passage number in 
H-RasV12/E1A-transformed cells. B: Representative recordings of NADH autofluorescence in Ras-LP and Ras-TUM cells 
before and after rotenone application. Rotenone inhibition of Complex I results in a differential increase in NADH autofluores-
cence. The percentage NADH autofluorescence is indicative of different rates of mitochondrial respiration. These data confirm 
the relatively higher respiration rates in Ras-LP cells. C: Cumulative data from n = 3 NADH autofluorescence/rotenone analy-
ses carried out on separate days, with a minimum of 3 coverslips per day. Note that this parameter is cell morphology-inde-
pendent. **:p < 0.01 compared to Prim-MEF ##:p < 0.01 for Ras-LP – Ras-TUM intercomparison (one-way ANOVA/
Bonferroni). D: Superoxide levels expressed as fluorescence signal of HEt oxidation products per cell. Ras-LP levels were arbi-
trarily set at 100%. Oxygen consumption data per cell are available in Additional file 1, Fig. S4B and Fig. S4D. HEt fluorescence 
in Ras-LP, HP and TUM cells was determined in three independent experiments, each in duplicate, with at least 20,000 cells per 
assay. Prim-MEF, Imm-MEF and TBX2-MEF HEt fluorescence was determined in one experiment, in duplicate. Superoxide lev-
els correlate with respiration rates measured in (B) and (C). ##:p < 0.01 compared to Ras-LP in a Student's t-test.
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in continuous presence of 21% environmental oxygen
and under constant medium conditions. Strikingly, H-
RasV12/E1A expression only marginally affected protein
expression levels of glycolytic, TCA and OXPHOS
enzymes at all stages after transformation, implying that
altered flux rates dominate and underlie the observed
metabolic effects. The shift in mitochondrial NAD+/
NADH ratio that we observed is in support of this model,
as this ratio sets the flux rate of key metabolic reactions.
Adaptive changes in mitochondrial function, with or
without further genetic programming, may provide
growth- and survival advantage by conferring resistance to
apoptotic cell death [31]. Cells with electron flow through
the ETC and enhanced glycolytic flux may perform best, as
these are properties associated with reduced ROS produc-
tion and increased ROS scavenging ability, respectively.
ROS induced damage is a well-known factor in cell viabil-
ity control [7]. Indeed, in the H-RasV12/E1A cells mito-
chondria are the primary ROS source, as we observed a
direct relationship between oxygen consumption and
superoxide production. Indirect support for this relation-
ship was also provided by our finding on glucose-galac-
tose shift effects in TBX2-MEF cells.
We would like to emphasize that mechanisms other than
those based on mitochondria-derived ROS effects could
also explain the apparent coupling between tumor pro-
gression and increased glycolytic rate. Firstly, the meta-
bolic infrastructure of cells could have changed due to
Ras-induced alterations in cell morphology and cytoarchi-
tecture. Cell surface changes, cell clustering, attachment
and movement are processes that are coupled to actin
cytoskeleton rearrangements. Bereiter-Hahn and co-work-
ers [32] showed that changes in energy metabolism may
result from rearrangements of the F-actin network, and
conversely, that energy demand of motile actin-based
structures is supplied predominantly by ATP derived from
glycolysis. At the same time, mitochondrial dynamics are
determined by a complex interplay between the inner
membrane-matrix complex and cytoskeletal elements
outside, possibly via F-actin and dynamin-related protein
DRP1 [33]. Upregulation of glycolysis or alteration of
mitochondrial properties may thus be directly coupled to
Ras-induced cytoskeletal remodeling, and fulfill new
needs for development of anchorage independent growth,
or other essential prerequisites for tumorigenic progres-
sion.
As another speculative possibility, there may also be a
connection between cell cycle progression and the bal-
ance between glycolytic or oxidative metabolism. H-
RasV12 induces cell cycle progression via enhanced G1 to
S phase transition [34], and also the E1A oncoprotein
induces S-phase via induction of p300/CBP and c-Myc
[35]. Recently, it was reported that slowly growing yeast
cells in a low glucose environment exhibit a periodic met-
abolic cycle that alternates between glycolysis and respira-
tion, where the cell division cycle is constrained to the
reductive non-respiratory phase of this cycle, with DNA
replication taking place only during the glycolytic phase
[36,37]. If extrapolation of the yeast model to the situa-
tion in mammalian cells is valid, our findings may suggest
that glycolysis is the default metabolic pathway adapted
by Ras-transformed cells with enhanced proliferation
capacity.
Finally, our findings can also be explained by early altera-
tions in NAD+/NADH setpoint, acting as driver for subse-
quent changes in tumorigenic conversion. We consider
this an interesting possibility because we observed
changes in set point level of NAD(H) (NAD+ plus NADH)
metabolites and upregulation of NAMPT protein levels as
parallel immediate early effects of H-RasV12/E1A trans-
formation in our RAS-LP-HP-TUM series. Van der Veer et
al. [38] reported that overexpression of NAMPT results in
increased life span and resistance to oxidative stress. Our
data show that total cellular NAD(H) levels increase upon
cellular transformation and may relate to the simultane-
ous upregulation of the NAD-salvaging enzyme NAMPT
at the protein level. Evidence is now accumulating that
NAD+ levels, and/or redox state of the NAD+/NADH cou-
ple in cytosol, nucleus and mitochondria are key factors in
transcriptional regulation [39,40], modulation of growth-
differentiation decisions in dividing cells [41], and sur-
vival control [42]. Moreover, the need for NAD+ or NADH
as essential co-factors in regulation of metabolic flux rates
is already long known. While we regard our work as a first
proof-of-concept it is clear that more study into these reg-
ulatory circuits – including those in human cells of differ-
ent tissue origin – is necessary to draw definite
conclusions about the control over early and late events in
the Warburg transition.
Conclusion
We show that H-RasV12/E1A transformation of cells
causes instantaneous and dramatic upregulation of mito-
chondrial ETC-OXPHOS activity, and not aerobic glycoly-
sis. This brings newly transformed cells in a dangerous
metabolic balance, reflected by a high rate of cell death. At
this early stage, cells have a limited capacity for anchorage
independent growth. Based on our findings we hypothe-
size that cells then traverse an "adapt-or-perish" period.
Those that develop enhanced glycolysis and relatively low
mitochondrial activity have increased survival chances,
adapt further, and commonly develop the Warburg phe-
notype of tumorigenic cells. Our data predict that early-
transformed cells, with high OXPHOS activity and the
potential to serve as founders for new tumor masses, may
be missed in positron emission tomography images or
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escape therapies aimed at metabolic inhibition of tumors
with a fully developed Warburg phenotype.
Methods
Cell culture
For routine propagation, cells at all stages were kept under
identical culture conditions with high nutrient and oxy-
gen supply, with the exception of Ras-TUM cells, which
were in an in vivo tumor environment for a four-week
period. Cells were grown in DMEM (25 mM glucose, Inv-
itrogen, Breda, The Netherlands) supplemented with 4
mM glutamine, 1 mM pyruvate and 10% Fetal Calf Serum
(FCS, Greiner Bio-One, Alphen aan den Rijn, The Nether-
lands) in 21% environmental oxygen conditions or in 2%
oxygen conditions where indicated. Primary MEFs were
derived from E12.5–14 dpc mouse embryos [43] with a
heterogeneous C57BL/6/129Ola background and frozen
at passage 1. We subsequently derived all other cell popu-
lations from this pool of MEF cells as described in the
Results section. In some experiments, cells were cultured
in glucose-free DMEM (Invitrogen) supplemented with
10% dialyzed FBS and 10 mM galactose to stimulate oxi-
dative phosphorylation [44]. Details on retroviral trans-
duction are available in Additional file 2.
Microscopy, cell morphology and cell size analysis
Protocols and equipment for microscopy and cell size
analysis are available in the Additional file 2.
Soft agar assay and injection of cells in immune-deficient 
mice
Procedures for analysis of anchorage-indepent growth
characteristics and tumor growth in immune-deficient
mice, adopted from Vasseur et al. (2003) [14], are
described in Additional file 2.
Growth curves and metabolic profiling
For simultaneous determination of cell growth rate and
lactic acid production, cells were seeded in 6-well plates.
Medium was harvested and cells were counted at 24 h, 48
h, and 72 h. Lactic acid levels were determined using the
Amplex Red glucose/glucose oxidase kit (Molecular
Probes, Leiden, The Netherlands), with lactate oxidase
(Sigma-Aldrich) in the reaction instead of glucose oxi-
dase. Growth curves, cell doubling time and average cell
number per hour were calculated in the exponential
growth phase (24–72 hrs) to obtain metabolite produc-
tion/consumption per average cell in culture. These num-
bers were converted to metabolite production/
consumption per mg.
Oxygen consumption
Cells were trypsinized, counted, resuspended in culture
medium and transferred to the BD Oxygen Biosensor 384
multi-well plates (Becton Dickinson, Erembodegem-
Aalst, Belgium). Cellular oxygen consumption was deter-
mined in culture medium, and in medium supplemented
with FCCP (2 μM), oligomycin (2.5 μM), myxothiazol (1
μM) or NADH (1 μM; all Sigma-Aldrich). Fluorescence
(485 nm excitation, 612 nm emission) was recorded in a
POLARstar Optima Fluorescence polarization plate reader
(BMG Labtech, IJsselstein, The Netherlands) in 2-min
intervals at 37°C for 4 hrs. The maximum slope of fluores-
cence units/min was calculated and converted into nor-
malized relative fluorescence units (NRFU/min).
Real-time metabolic analysis
Simultaneous multiparameter metabolic analysis of cell
populations in culture was performed in the Seahorse
XF24 extracellular flux analyzer (Seahorse Bioscience, Bill-
erica, MA, USA) as described by Wu et al. [17]. All six cell
lines were cultured in growth medium for 48 hours in
plate before real-time metabolic analysis. At the start of
the assay, growth medium was removed and replaced
with DMEM medium containing 5% FBS (free of bicarbo-
nate). Basal OCR (oxygen consumption rate) and PPR
(proton production rate) of the cells were measured
repeatedly in 30 minutes. After XF assay, cells were har-
vested by trypsin-EDTA treatment and counted on ViCell
(Beckman Coulter, Fullerton, CA, USA). The number of
cells per well were used to normalize OCR and PPR.
Lysate preparation and Western blot
Semi-quantitative Western Blot analysis was performed as
described by De Groof et al. [45]. Details are available in
Additional file 2.
HPLC
For HPLC analysis, six 10 cm dishes (Prim, Imm-MEF,
TBX2-MEF) or 6-cm dishes (other cell lines) were cul-
tured. In each experiment, three plates were used for cell
counts; the other three for metabolite extraction using the
sample preparation method of Fiehn (MeOH/CHCl3
extraction method, see Additional file 2). We repeated the
entire experiment using a perchlorid acid extraction sam-
ple preparation method. This method allowed parallel
protein quantification using the Pierce BCA kit (Pierce,
Etten-Leur, The Netherlands). Further details of the HPLC
instrumentation and the experimental procedures are
available in Additional file 2.
Microscopic measurement of NAD(P)H autofluorescence
NAD(P)H autofluorescence levels were measured in the
experimental setup described by Verkaart et al. [46]. A
detailed description is available in Additional file 2.
Analysis of superoxide production
Cell cultures were incubated in HEPES-Tris medium con-
taining 10 μM hydroethidine (HEt; Molecular Probes) for
10 min at 37°C [46]. The reaction was stopped by thor-
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ough washing of the cells with PBS to remove excess HEt.
After trypsinization and fixation in 2% paraformalde-
hyde, cells were washed and transferred to FACS tubes.
Ethidium fluorescence was elicited by excitation at 488
nm and the emission signal detected at 540–600 nm or >
670 nm using FACScan equipment (Becton Dickinson).
Statistical analysis
Statistical analyses were performed by one-way ANOVA
and Bonferroni's multiple comparisons test. Pairwise
comparisons were made between Prim-MEF and all other
cell populations, or between Ras-LP and the other two
Ras-transformed populations. Other statistical analysis
methods are mentioned in the text.
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